Polo Oncologico Area Vasta Nord Ovest Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2010
NCT01358812
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Polo Oncologico Area Vasta Nord Ovest | Polo Oncologico Area Vasta Nord-Ovest

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 2)

Rectal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 8